
Whitepaper: Improving the predictive power of GPCR assays
How much of your compound’s activity are your assays really detecting? Understanding how receptor density impacts pharmacological responses is critical for accurately characterising compound activity & identifying candidates with the highest likelihood of therapeutic success. Explore this whitepaper by GPCR expert Terry Kenakin, PhD, and EurofinsDiscoverX to… Read More















